President Barack Obama is asking Congress for more than $1.8 billion in emergency funding to prepare the United States for Zika virus and support response efforts abroad, escalating the federal government’s commitment as concern grows about possible birth defects, sexual transmission and the risk of local mosquito-borne spread.

The White House proposal would direct new money toward the Centers for Disease Control and Prevention, the National Institutes of Health, vaccine and diagnostic development, mosquito control, support for states and territories, and international efforts to reduce transmission in Latin America and the Caribbean.

The request reflects a shift in the U.S. response from surveillance and travel guidance toward large-scale preparedness. Federal officials say most cases in the continental United States are still expected to involve travelers, but Aedes mosquitoes capable of carrying Zika live in parts of the country and local transmission has already been documented in the U.S. Virgin Islands.

More Than $1.8 Billion for Domestic and International Response

The White House plan calls for more than $1.8 billion in emergency funding across several federal agencies. The administration says the money would strengthen surveillance, laboratory testing, mosquito-control programs and public-health capacity in states and territories where transmission could occur.

Funds would also support research into the relationship between Zika infection and microcephaly, accelerate development of vaccines and diagnostics, and expand efforts to protect pregnant women and other people at elevated risk.

A portion of the request is intended for countries already experiencing widespread transmission. Administration officials argue that reducing infections abroad also protects the United States by lowering the number of infected travelers who could introduce the virus into local mosquito populations.

The proposal now requires congressional approval. Lawmakers are likely to examine how quickly agencies can use the money, whether existing funds can be redirected and how responsibilities should be divided among domestic and international programs.

Pregnancy Remains the Central Concern

Zika generally produces mild illness in adults, and most infected people experience no symptoms. The urgency surrounding the outbreak comes from a suspected association with microcephaly and other neurological abnormalities in babies born to women infected during pregnancy.

Brazil has reported a substantial increase in suspected microcephaly cases during the period in which Zika has spread widely. Researchers are working to determine how many of those cases are confirmed, how many involve maternal infection and what the actual risk is for an infected pregnancy.

Federal health officials continue to stress that important questions remain unanswered. Scientists have not yet established the probability that infection during pregnancy will result in fetal harm, and they are still studying whether the timing of infection changes the risk.

Even so, the CDC is recommending that pregnant women consider postponing travel to areas with active transmission. Healthcare providers are being asked to screen pregnant patients for travel history and coordinate testing with public-health departments when exposure is suspected.

Sexual Transmission Broadens Prevention Guidance

The federal response has also had to adapt to evidence that Zika can be transmitted sexually. A probable case in Dallas involved a person who became infected after sexual contact with a traveler returning from Venezuela.

The CDC now recommends that men who live in or travel to areas with active Zika transmission and have pregnant partners use condoms consistently or abstain from sex during the pregnancy.

The agency is still trying to determine how often sexual transmission occurs and how long the virus can persist in semen. Mosquitoes remain the principal route of spread, but sexual transmission creates a separate pathway that cannot be addressed through mosquito control alone.

That development is particularly relevant to obstetric care because a pregnant woman who never traveled to an affected area could still be exposed through a partner who did.

States Prepare for Warmer Weather

Winter temperatures limit mosquito activity across much of the continental United States, giving health departments time to strengthen surveillance before spring and summer.

States in the South face the greatest immediate concern because Aedes aegypti and related mosquitoes are more common there. Florida, Texas and other jurisdictions are reviewing mosquito-control plans, laboratory capacity and procedures for investigating travel-associated cases.

Public-health officials are also urging communities to reduce standing water where Aedes mosquitoes breed. Unlike some mosquitoes that reproduce mainly in large wetlands, Aedes mosquitoes often lay eggs in small containers around homes and businesses, including buckets, planters, tires and discarded materials.

That makes mosquito control partly a household and neighborhood responsibility. Government spraying alone may not eliminate breeding sites hidden on private property.

Laboratory Capacity Is Becoming a Major Need

As awareness increases, physicians are encountering more patients who want to know whether they have been infected. Testing remains technically complicated and is not yet available as a simple routine laboratory service in many communities.

Molecular tests can detect viral RNA during a limited period after infection, while antibody tests may cross-react with dengue and other related viruses. That means results can be difficult to interpret, particularly in people who have previously lived in or traveled through areas where multiple flaviviruses circulate.

The administration says emergency funding would help expand testing capacity and distribute diagnostic tools to public-health laboratories. Faster and more widely available testing would be especially important for pregnant women, for whom uncertainty can have serious clinical and emotional consequences.

Hospitals and physician practices are also developing workflows for collecting travel histories, counseling patients and coordinating specimens with state health departments.

Vaccine Development Will Take Time

The National Institutes of Health and other research organizations are beginning or accelerating work on Zika vaccines, drawing in part on experience with related viruses.

No licensed vaccine is currently available, and federal officials caution that development and testing will take time. Even a promising candidate must undergo laboratory work, manufacturing development and clinical trials before it can be used broadly.

The same is true for new antiviral treatments. At present, care for Zika is primarily supportive because there is no specific medicine that eliminates the infection.

That leaves prevention as the most important near-term tool: avoiding mosquito bites, reducing breeding sites, following travel guidance and taking precautions against sexual transmission.

Congress Will Determine the Scale of the Response

The administration’s funding request arrives as lawmakers are already debating the appropriate federal role in public-health emergencies and international disease control.

Supporters of rapid funding argue that early investment could reduce both health consequences and future costs by improving mosquito control, laboratory readiness and vaccine research before local transmission expands.

Others are likely to ask whether agencies can redirect money already appropriated for other infectious-disease programs and how the government will measure the effectiveness of emergency spending.

The debate will also test whether Congress can act quickly while scientific evidence is still developing. Public-health decisions often must be made before every uncertainty is resolved, particularly when preparation requires months of lead time.

From Travel Alert to National Preparedness

Only a few weeks ago, Zika was mainly presented to Americans as a travel concern. The CDC warned pregnant women about affected destinations and advised clinicians to consider infection in returning travelers.

The situation is now broader. Local transmission has occurred in a U.S. territory, probable sexual transmission has been reported in Texas, the World Health Organization has declared an international public-health emergency, and the White House is asking Congress for more than $1.8 billion.

That does not mean widespread mosquito-borne transmission is inevitable in the continental United States. It does mean federal and state health agencies are preparing for a possibility they do not want to confront unprepared.

The healthcare system’s immediate task is therefore one of readiness: identify infections, protect pregnancies, expand laboratory capability, reduce mosquitoes and build enough research capacity to answer questions that remain unresolved.

The administration’s request places a price on that preparation. Congress must now decide how much of the proposed response to fund and how quickly. With mosquito season approaching in much of the country, public-health officials are arguing that the most valuable time for preparation is before local outbreaks begin, not after.